Pediatric Rheumatology

unofficial impact factor 1.74
Search for
Advanced search
Pediatric Rheumatology
Tools

This article is part of the supplement: 15th Paediatric Rheumatology European Society (PreS) Congress

Open Access Poster presentation

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

SO Salugina1*, ES Fedorov1, EN Alexandrova1, AA Novikov1, MV Cherkasova1, AA Baranov2, YA Valogina2, TN Nikolaeva2 and NA Zubova2

  • * Corresponding author: SO Salugina

Author Affiliations

1 Institute of Rheumatology RAMS, Moscow, Russian Federation

2 Department of Clinical Pathology, Yaroslavl Medical Academy, Yaroslavl, Russian Federation

For all author emails, please log on.

Pediatric Rheumatology 2008, 6(Suppl 1):P9 doi:10.1186/1546-0096-6-S1-P9

Published: 15 September 2008

First paragraph (this article has no abstract)

To investigate the diagnostic value and clinical significance of anti-MCV in pts with early JA.